Generic medicine

Imatinib Myselate

Imatinib Myselate · ATC L01 · Oncology & immunology · Antineoplastic medicines

Data statusRegistration & price fields require source verification.

1brand families

2registered presentations

1companies

2with current prices

Available dosage forms

Choose a form

Tap a form to filter the brand list

Tablet2 products

Advertisement · clearly labelled sponsored placement

Pakistan brand index

Available brands

One brand is shown once per manufacturer; strengths, forms, packs and DRAP registrations remain visible as separate presentations.

Print / Save PDFAll 2 presentations 1 brands · 2 presentations

Brand	Manufacturer	Registered presentations
IMATIB2 presentations	AJM Pharma (Pvt.) Limited	400 mg Tablet 10's 088384 PKR 27,409.562025-08-19 PKR 2,740.96/ tablet 400 mg Tablet 30's 088384 PKR 86,289.042026-08-20 PKR 2,876.30/ tablet

Price movement

Official price changes for Imatinib Myselate

No change in the official DRAP price is recorded yet for any of the 2 tracked presentations (records from 19 Aug 2025).

Independent editorial layer

Medicine information

Clinical monographs should be independently written, referenced and medically reviewed. Product listings and advertisements must not determine clinical conclusions.

Cite this record

Molecule record · ATC L01

MedInfoBase. (2026). Imatinib Myselate — registered brands and price distribution in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/generic/imatinib-myselate/ ATC L01.

Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.